Health Winners and Losers: Celgene TheStreet.com Among the earnings releases, Cypress Bioscience(CYPB Quote - Cramer on CYPB - Stock Picks) swung to a second-quarter loss of $7.2 million, or 19 cents a share, as revenue fell and costs increased. Shares were down 5.8%, or 47 cents, but volume was ... |
Tuesday, March 17, 2009
Health Winners and Losers: Celgene - TheStreet.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment